IP Library Granted Patent US 12,564,505
Granted Patent B2
US 12,564,505 · App. 18/520,223 · Granted Mar 3, 2026

Aortic pressure loss reduction apparatus and methods

Inventors: Sagy Karavany (Kibbutz Dvir, IL); Menashe Yacoby (Shoham, IL); Tanhum Feld (Moshav Merhavya, IL)
Assignee: HEMODYNAMX-TECHNOLOGIES LTD.
A61F2/9662A61F2/07A61F2/848A61F2/915A61F2002/068A61F2002/8486A61F2002/91541A61F2230/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,564,505
App. No.
18/520,223
Granted
Mar 3, 2026
Kind
B2
Abstract

Apparatus and methods are described including implanting an aortic pressure-loss-reduction device in a subject's ascending aorta. A frame of the device includes a first set of sinusoidal struts disposed between a downstream end of an upstream anchor and an upstream end of the intermediate portion, the sinusoidal struts being shaped to form a folded portion between the downstream end of the upstream anchor and the upstream end of the intermediate portion. The frame includes a second set of sinusoidal struts disposed between an upstream end of a downstream anchor and a downstream end of the intermediate portion, the sinusoidal struts being shaped to form a folded portion between the upstream end of the downstream anchor and the downstream end of the intermediate portion. Other applications are also described.

Claims (42)

1 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of a subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion configured to radially expand against an inner wall of a subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of sinusoidal struts disposed between a downstream end of the upstream anchor and an upstream end of the intermediate portion, the sinusoidal struts being shaped to form a folded portion between the downstream end of the upstream anchor and the upstream end of the intermediate portion; and

a second set of sinusoidal struts disposed between an upstream end of the downstream anchor and a downstream end of the intermediate portion, the sinusoidal struts being shaped to form a folded portion between the upstream end of the downstream anchor and the downstream end of the intermediate portion; and

a material layer coupled to the frame, the material layer configured to impede blood flow therethrough.

2 . The apparatus according to claim 1 , wherein the sinusoidal struts belonging to the first set of sinusoidal struts are longer than the sinusoidal struts belonging to the second set of sinusoidal struts.

3 . The apparatus according to claim 1 , wherein the first set of sinusoidal struts is configured such that a distance from an upstream end of the upstream anchor to an upstream end of the conduit is less than 15 mm.

4 . The apparatus according to claim 1 , wherein the first set of sinusoidal struts is configured such that an upstream end of the conduit extends beyond an upstream end of the upstream anchor in the upstream direction.

5 . The apparatus according to claim 1 , wherein the aortic pressure-loss-reduction device is configured, such that the intermediate portion of the device is (a) longitudinally fixed with respect to the ascending aorta by the upstream anchor portion and the downstream anchor portion exerting radial force against the inner wall of the ascending aorta and (b) able to adjust the angle that a longitudinal axis of the intermediate portion makes with longitudinal axes of the upstream and downstream anchor portions, by the folded portions acting as hinges about which the intermediate portion can flex.

6 . The apparatus according to claim 1 , wherein the aortic pressure-loss-reduction device is configured such that, by virtue of a flexibility of the folded portions, a length of the intermediate portion does not change even if a distance between the upstream and downstream anchor portions changes.

7 . The apparatus according to claim 1 , wherein the aortic pressure-loss-reduction device is configured such that in response to a diameter of the upstream anchor changing by a given absolute amount, a diameter of an upstream end of the conduit does not change by the given absolute amount.

8 . The apparatus according to claim 1 , wherein an upstream end of the intermediate portion is reinforced with respect to at least a longitudinally-central portion of the intermediate portion, such that in response to a diameter of the upstream anchor changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor changed.

9 . The apparatus according to claim 1 , wherein the sinusoidal struts belonging to the first set of sinusoidal struts are configured to have a flexibility that is such that in response to a diameter of the upstream anchor changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor changed.

10 . The apparatus according to claim 1 , wherein the aortic pressure-loss-reduction device further comprises a plurality of projections from an upstream end of the upstream anchor portion, the projections being configured to facilitate holding the upstream anchor portion in a radially-constrained configuration, even when the intermediate portion is at least partially in a non-radially-constrained configuration.

11 . A method comprising:

placing an aortic pressure-loss-reduction device inside an ascending aorta of a subject, the aortic pressure-loss-reduction device including a frame and a material layer coupled to an inside of at least a portion of the frame, the material being configured to impede blood flow therethrough; and

deploying the aortic pressure-loss-reduction device inside the ascending aorta, such that the frame of the aortic pressure-loss-reduction device defines:

an upstream anchor portion that radially expands against an inner wall of a subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion that defines a conduit therethrough, such that blood flows through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion;

a downstream anchor portion that radially expands against an inner wall of a subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

a first set of sinusoidal struts disposed between a downstream end of the upstream anchor and an upstream end of the intermediate portion, the sinusoidal struts forming a folded portion between the downstream end of the upstream anchor and the upstream end of the intermediate portion; and

a second set of sinusoidal struts disposed between an upstream end of the downstream anchor and a downstream end of the intermediate portion, the sinusoidal struts forming a folded portion between the upstream end of the downstream anchor and the downstream end of the intermediate portion.

12 . The method according to claim 11 , wherein the sinusoidal struts belonging to the first set of sinusoidal struts are longer than the sinusoidal struts belonging to the second set of sinusoidal struts.

13 . The method according to claim 11 , wherein deploying the aortic pressure-loss-reduction device inside the ascending aorta comprises deploying the aortic pressure-loss-reduction device inside the ascending aorta with the first set of sinusoidal struts being configured such that a distance from an upstream end of the upstream anchor to an upstream end of the conduit is less than 15 mm.

14 . The method according to claim 11 , wherein deploying the aortic pressure-loss-reduction device inside the ascending aorta comprises deploying the aortic pressure-loss-reduction device inside the ascending aorta, such that the intermediate portion of the device is (a) longitudinally fixed with respect to the ascending aorta by the upstream anchor portion and the downstream anchor portion exerting radial force against the inner wall of the ascending aorta and (b) able to adjust the angle that a longitudinal axis of the intermediate portion makes with longitudinal axes of the upstream and downstream anchor portions, by the folded portions acting as hinges about which the intermediate portion can flex.

15 . The method according to claim 11 , wherein deploying the aortic pressure-loss-reduction device inside the ascending aorta comprises deploying the aortic pressure-loss-reduction device inside the ascending aorta, such that, by virtue of a flexibility of the folded portions, a length of the intermediate portion does not change even if a distance between the upstream and downstream anchor portions changes.

16 . The method according to claim 11 , wherein deploying the aortic pressure-loss-reduction device inside the ascending aorta comprises deploying the aortic pressure-loss-reduction device inside the ascending aorta, such that in response to a diameter of the upstream anchor changing by a given absolute amount, a diameter of an upstream end of the conduit does not change by the given absolute amount.

17 . The method according to claim 11 , wherein an upstream end of the intermediate portion is reinforced with respect to at least a longitudinally-central portion of the intermediate portion, such that in response to a diameter of the upstream anchor changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor changed.

18 . The method according to claim 11 , wherein the sinusoidal struts belonging to the first set of sinusoidal struts are configured to have a flexibility that is such that in response to a diameter of the upstream anchor changing by an absolute amount, an absolute change in a diameter of the upstream end of the intermediate portion is less than the absolute amount by which the diameter of the upstream anchor changed.

19 . The method according to claim 11 , wherein the aortic pressure-loss-reduction device includes a plurality of projections from an upstream end of the upstream anchor portion, the projections being configured to facilitate holding the upstream anchor portion in a radially-constrained configuration, even when the intermediate portion is at least partially in a non-radially-constrained configuration.

20 . Apparatus comprising:

an aortic pressure-loss-reduction device configured to be implanted inside an ascending aorta of a subject, the aortic pressure-loss-reduction device comprising:

a frame that is configured, in a non-constrained configuration thereof, to define:

an upstream anchor portion configured to radially expand against an inner wall of a subject's ascending aorta, such as to anchor an upstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta;

an intermediate portion configured to define a conduit therethrough, such that blood is configured to flow through the device via the conduit, at least a portion of the conduit diverging, such that a downstream end of the diverging portion has a greater cross-sectional area than an upstream end of the diverging portion, the conduit at least partially overlapping with the upstream anchor along a longitudinal direction of the aortic pressure-loss-reduction device;

a downstream anchor portion configured to radially expand against an inner wall of a subject's ascending aorta, such as to anchor a downstream end of the aortic pressure-loss-reduction device to the subject's ascending aorta; and

anchor extensions configured to extend from the upstream anchor portion, the anchor extensions being shape set, such that when the device is deployed within the subject's ascending aorta, the anchor extensions exert an outward radial force upon the inner wall of a subject's ascending aorta, to thereby reinforce anchoring of the upstream anchor portion within the subject's ascending aorta; and

a material layer coupled to the frame, the material layer configured to impede blood flow therethrough.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2025
From: HEMODYNAMX TECHNOLOGIES LTD.
To: HEMODYNAMX LTD.
Reel/Frame 069909/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2023
From: KARAVANY, SAGY; YACOBY, MENASHE; FELD, TANHUM
To: HEMODYNAMX-TECHNOLOGIES LTD.
Reel/Frame 065671/0435 →
Continuity (5)
Continuation 17526053 · Nov 15, 2021
Continuation 16763884
Provisional Application 62630406 · Feb 14, 2018
Provisional Application 62586258 · Nov 15, 2017
Related Publication 20240091037A1 · Mar 21, 2024
References Cited (131)
US 5139515A · Robicsek · 1992 [cited by applicant]
US 6120534A · Ruiz · 2000 [cited by applicant]
US 7018404B2 · Holmberg et al. · 2006 [cited by applicant]
US 7429269B2 · Schwammenthal et al. · 2008 [cited by applicant]
US 7766814B2 · Walsh · 2010 [cited by applicant]
US 8585572B2 · Mehmanesh · 2013 [cited by applicant]
US 8623065B2 · Lau et al. · 2014 [cited by applicant]
US 8715337B2 · Chuter · 2014 [cited by applicant]
US 9232992B2 · Heidner et al. · 2016 [cited by applicant]
US 10368985B2 · Wilson et al. · 2019 [cited by applicant]
US 10568731B2 · Karavany et al. · 2020 [cited by applicant]
US 11207200B2 · Karavany et al. · 2021 [cited by applicant]
US 11224503B2 · Karavany et al. · 2022 [cited by applicant]
US 20030045828A1 · Wilk · 2003 [cited by applicant]
US 20040093058A1 · Cottone et al. · 2004 [cited by applicant]
US 20040249439A1 · Richter et al. · 2004 [cited by applicant]
US 20040260389A1 · Case et al. · 2004 [cited by applicant]
US 20050055082A1 · Ben Muvhar · 2005 [cited by applicant]
US 20050222674A1 · Paine · 2005 [cited by applicant]
US 20050228480A1 · Douglas · 2005 [cited by applicant]
US 20060009835A1 · Osborne et al. · 2006 [cited by applicant]
US 20060106449A1 · Ben · 2006 [cited by applicant]
US 20060149360A1 · Schwammenthal et al. · 2006 [cited by applicant]
US 20060178552A1 · Gross · 2006 [cited by applicant]
US 20060259134A1 · Schwammenthal et al. · 2006 [cited by applicant]
US 20060271171A1 · Mcquinn et al. · 2006 [cited by applicant]
US 20070185565A1 · Schwammenthal et al. · 2007 [cited by applicant]
US 20070293808A1 · Williams et al. · 2007 [cited by applicant]
US 20080071361A1 · Tuval et al. · 2008 [cited by applicant]
US 20080071363A1 · Tuval et al. · 2008 [cited by applicant]
US 20090105805A1 · Baker et al. · 2009 [cited by applicant]
US 20090198315A1 · Boudjemline · 2009 [cited by applicant]
US 20090210047A1 · Amplatz et al. · 2009 [cited by applicant]
US 20090222078A1 · Greenberg · 2009 [cited by applicant]
US 20090240320A1 · Tuval et al. · 2009 [cited by applicant]
US 20090270965A1 · Sinha et al. · 2009 [cited by applicant]
US 20100023046A1 · Heidner et al. · 2010 [cited by applicant]
US 20100145433A1 · Anukhin et al. · 2010 [cited by applicant]
US 20110288634A1 · Tuval et al. · 2011 [cited by applicant]
US 20120010690A1 · Richter et al. · 2012 [cited by applicant]
US 20120022629A1 · Perera et al. · 2012 [cited by applicant]
US 20130013053A1 · Hartley et al. · 2013 [cited by applicant]
US 20130144383A1 · Thill et al. · 2013 [cited by applicant]
US 20130178750A1 · Sheehan et al. · 2013 [cited by applicant]
US 20140121757A1 · Debruyne · 2014 [cited by applicant]
US 20140222142A1 · Kovalsky · 2014 [cited by applicant]
US 20140257474A1 · Roeder · 2014 [cited by applicant]
US 20150238315A1 · Rabito et al. · 2015 [cited by applicant]
US 20150366693A1 · Kagan et al. · 2015 [cited by applicant]
US 20170042551A1 · Celermajer et al. · 2017 [cited by applicant]
US 20170340460A1 · Rosen · 2017 [cited by examiner]
US 20180036109A1 · Karavany et al. · 2018 [cited by applicant]
US 20180353281A1 · Nussinovitch · 2018 [cited by applicant]
US 20190183629A1 · Karavany et al. · 2019 [cited by applicant]
US 20210169634A1 · Karavany et al. · 2021 [cited by applicant]
US 20220071788A1 · Karavany et al. · 2022 [cited by applicant]
CN 101287424A · 2008 [cited by applicant]
EP 1849440A1 · 2007 [cited by applicant]
EP 2016961B1 · 2010 [cited by applicant]
EP 2777618A1 · 2014 [cited by applicant]
EP 2896387A1 · 2015 [cited by applicant]
EP 2785277B1 · 2017 [cited by applicant]
JP 2001527453A · 2001 [cited by applicant]
JP 2007526789A · 2007 [cited by applicant]
JP 2008537891A · 2008 [cited by applicant]
JP 2011502628A · 2011 [cited by applicant]
WO 9852476A1 · 1998 [cited by applicant]
WO 03028522A2 · 2003 [cited by applicant]
WO 2005002466A2 · 2005 [cited by applicant]
WO 2005084730A1 · 2005 [cited by applicant]
WO 2006070372A2 · 2006 [cited by applicant]
WO 2006080010A2 · 2006 [cited by applicant]
WO 2009061419A1 · 2009 [cited by applicant]
WO 2012018590A1 · 2012 [cited by applicant]
WO 2015013344A2 · 2015 [cited by applicant]
WO 2016128983A1 · 2016 [cited by applicant]
WO 2018029688A1 · 2018 [cited by applicant]
WO 2018220589A1 · 2018 [cited by applicant]
WO 2019097424A2 · 2019 [cited by applicant]
WO 2020234787A1 · 2020 [cited by applicant]
Communication Pursuant to Article 94(3) EPC for European Patent Application No. 16748842.8 mailed Jun. 17, 2022. [cited by applicant]
European Search Report for European Application No. 16748842.8 mailed Sep. 19, 2018. [cited by applicant]
Examination Report for European Application No. 16748842.8 mailed Jun. 17, 2022. [cited by applicant]
Examination Report for European Application No. 17755260.1 mailed Jun. 1, 2023. [cited by applicant]
Examination Report for Indian Application No. 201717029373 mailed Oct. 8, 2020. [cited by applicant]
Extended European Search Report for European Application No. 18878693.3 mailed Jul. 8, 2021. [cited by applicant]
Final Office Action for U.S. Appl. No. 15/550,661 mailed Jun. 19, 2019. [cited by applicant]
First Action Interview Pilot Program Pre-Interview Communication for U.S. Appl. No. 16/743,721 mailed Dec. 3, 2021. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2018/058961 mailed May 8, 2019. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IB2020/054761 mailed Oct. 28, 2020. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2016/050170 mailed Jun. 10, 2016. [cited by applicant]
International Search Report and Written Opinion from International Application No. PCT/IL2017/050884 mailed Oct. 30, 2017. [cited by applicant]
Issue Notification for U.S. Appl. No. 15/550,661 mailed Feb. 5, 2020. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/322,047 mailed Dec. 28, 2021. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/763,884 mailed Dec. 8, 2021. [cited by applicant]
Issue Notification for U.S. Appl. No. 16/743,721 mailed May 25, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/526,053 mailed Jan. 12, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/550,661 mailed Aug. 6, 2019. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/550,661 mailed Feb. 20, 2019. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/322,047 mailed Mar. 3, 2021. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 15/550,661 mailed Oct. 17, 2019. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/322,047 mailed Sep. 14, 2021. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/743,721 mailed Feb. 22, 2022. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/763,884 mailed Aug. 16, 2021. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/526,053 mailed Aug. 30, 2023. [cited by applicant]
Notice of Publication for U.S. Appl. No. 16/322,047 mailed Jun. 20, 2019. [cited by applicant]
Office Action for Chinese Application No. 201680015323.5 mailed Dec. 14, 2018. [cited by applicant]
Office Action for Chinese Application No. 201780049360.2 mailed May 25, 2021. [cited by applicant]
Office Action for Chinese Application No. 201780049360.2 mailed Oct. 10, 2020. [cited by applicant]
Office Action for Chinese Application No. 201880086395.8 mailed Jan. 18, 2023. [cited by applicant]
Office Action for Chinese Application No. 201910988467.4 mailed May 24, 2021. [cited by applicant]
Office Action for Japanese Application No. 2017-542883 mailed Dec. 10, 2019. [cited by applicant]
Protege webpage—downloaded Mar. 19, 2015. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 15/550,661 mailed Dec. 4, 2018. [cited by applicant]
Restriction Requirement for U.S. Appl. No. 16/743,721 mailed Sep. 1, 2021. [cited by applicant]
Supplemental Notice of Allowability for U.S. Appl. No. 15/550,661 mailed Jan. 23, 2020. [cited by applicant]
U.S. Appl. No. 15/550,661, filed Aug. 11, 2017. [cited by applicant]
U.S. Appl. No. 16/322,047, filed Jan. 30, 2019. [cited by applicant]
U.S. Appl. No. 16/743,721, filed Jan. 15, 2020. [cited by applicant]
U.S. Appl. No. 16/763,884, filed May 13, 2020. [cited by applicant]
U.S. Appl. No. 17/526,053, filed Nov. 15, 2021. [cited by applicant]
U.S. Appl. No. 62/115,207, filed Feb. 12, 2015. [cited by applicant]
U.S. Appl. No. 62/265,571, filed Dec. 10, 2015. [cited by applicant]
U.S. Appl. No. 62/373,993, filed Aug. 12, 2016. [cited by applicant]
U.S. Appl. No. 62/586,258, filed Nov. 15, 2017. [cited by applicant]
U.S. Appl. No. 62/630,406, filed Feb. 14, 2018. [cited by applicant]
U.S. Appl. No. 62/850,656, filed May 21, 2019. [cited by applicant]
Heinrich, et al., “Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery”, Annals of biomedical engineering, 1996, pp. 685-694. [cited by applicant]
Hearing Notice for Indian Application No. 201717029373 mailed Jan. 18, 2024. [cited by applicant]
Issue Notification for U.S. Appl. No. 17/526,053 mailed Dec. 20, 2023. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/611,668 mailed Apr. 25, 2025. [cited by applicant]